News Room

  • February 19, 2015
    CRO Leadership Awards — Altasciences Recognized for Leadership

    Altasciences is pleased to announce that its companies, Algorithme Pharma (Montreal, Canada) and Vince & Associates Clinical Research (Kansas, USA), are both 2015 CRO Leadership Award recipients.

  • February 10, 2015
    Algorithme Pharma USA has its First Studies Underway

    Last October, Altasciences expanded into the United States with the opening of Algorithme Pharma USA, in Fargo, North Dakota. Today, we are pleased to announce that our first studies were initiated and completed in January, just 91 days from the US contract being signed, and despite the holiday hustle.

  • February 5, 2015
    Vince & Associates Clinical Research Qualified as Early Phase Provider for Clinical Evaluation of Thorough QT

    Vince & Associates Clinical Research, a premier provider of early phase clinical research services, announced today it has become the first “iCardiac Certified Site.” iCardiac is a major provider of cardiac safety services.

  • January 14, 2015
    Vince & Associates Clinical Research Joins Cardiac Safety Research Consortium

    Vince & Associates Clinical Research announced today its membership into the Cardiac Safety Research Consortium (CSRC). As a member of the CSRC, Vince & Associates will participate with industry leaders on key issues that impact cardiovascular safety, including alternative approaches to ICH E14 for the assessment of arrhythmia liability in early drug development.

  • December 18, 2014
    Dyax Corp.’s First-in-Human Trial for DX-2930 Conducted by Vince and Associates Clinical Research Featured in the Annals of Allergy, Asthma & Immunology

    Vince & Associates Clinical Research, a premier provider of early phase clinical research services to the global biopharmaceutical industry, announced the release of the print publication of scientific data for Dyax Corp.’s (Dyax) DX-2930 monoclonal antibody in a first-in-human study in the Annals of Allergy, Asthma & Immunology.

Pages